Literature DB >> 16544330

Pregnancy-associated anaplastic large-cell lymphoma of the breast: a rare mimic of ductal carcinoma.

P Iyengar1, M Reid-Nicholson, A L Moreira.   

Abstract

Anaplastic large-cell lymphoma (ALCL) is a rare T-cell lymphoma typically seen in children and young adults. It has been described in numerous sites; however, the breast is one of the least common locations. We herein report a case of ALCL arising in the breast of a 36-yr-old pregnant woman. To our knowledge this is the second such case in the English literature. We would like to highlight the cytologic and histologic features of ALCL, as this case was initially misdiagnosed as a ductal carcinoma. Differential diagnosis with other tumors is also discussed. This case serves to emphasize the importance of the triple test, and the need for correlation of fine-needle aspiration findings with core biopsy findings in breast tumor management.

Entities:  

Mesh:

Year:  2006        PMID: 16544330     DOI: 10.1002/dc.20442

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  4 in total

1.  Primary anaplastic lymphoma kinase-negative anaplastic large-cell lymphoma of the breast in a male patient.

Authors:  E S Ko; H Seol; J H Shin; E Y Ko
Journal:  Br J Radiol       Date:  2012-04       Impact factor: 3.039

2.  ALK-positive anaplastic large cell lymphoma of the thoracic spine occurring in pregnancy: A case report.

Authors:  Sen Yang; Wei-Min Jiang; Hui-Lin Yang
Journal:  World J Clin Cases       Date:  2019-09-26       Impact factor: 1.337

3.  Primary Lymphomas of the Breast: A Review.

Authors:  Emily R James; Roberto N Miranda; Suzanne D Turner
Journal:  JPRAS Open       Date:  2022-02-20

4.  Primary anaplastic large cell lymphoma of the breast arising in reconstruction mammoplasty capsule of saline filled breast implant after radical mastectomy for breast cancer: an unusual case presentation.

Authors:  Mona R Y Bishara; Cathy Ross; Monalisa Sur
Journal:  Diagn Pathol       Date:  2009-04-02       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.